Blau Farmacêutica Investor Relations Material
Latest events
Q1 2025
Blau Farmacêutica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Blau Farmacêutica S.A
Access all reports
Blau Farmacêutica S.A. develops and manufactures pharmaceuticals with a focus on biotechnology-based products. Its portfolio includes hospital-use medications and therapies for oncology, nephrology, and infectious diseases. The company is headquartered in Cotia, Brazil, and its shares are listed on the B3.
Key slides for Blau Farmacêutica S.A
Q1 2025
Blau Farmacêutica S.A
Q1 2025
Blau Farmacêutica S.A
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BLAU3
Country
🇧🇷 Brazil